Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
Not Applicable
Completed
- Conditions
- CryptosporidiosisHIV Infections
- Registration Number
- NCT00002082
- Lead Sponsor
- Pfizer
- Brief Summary
To evaluate the safety and efficacy of azithromycin in the treatment of intestinal cryptosporidial infection in AIDS patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Infectious Disease Med Group
🇺🇸Oakland, California, United States
UCSD Med Ctr
🇺🇸San Diego, California, United States
Cornell Univ Med Ctr
🇺🇸New York, New York, United States
Univ of Tennessee
🇺🇸Memphis, Tennessee, United States
Infectious Disease Med Group🇺🇸Oakland, California, United States